ArticleeLife2022
Human monoclonal antibodies against
Open access · goldAbstract read
In one paragraph
Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 38 citations in OpenAlex.
- Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026Review
- The Effects of Radioimmunotherapy and Antibiotics on Biofilm-Associated Implant Infections in a Preclinical Rat Model.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026Article
- ImmunoPET with Zirconium-89 specifically detects postoperative biofilm-associated implant infections: a preclinical study.EJNMMI research · 2026Article
- Antibody-Antibiotic Conjugates: Mechanisms, Clinical Progress, and Next-Generation Strategies Against Multidrug-Resistant Bacterial Infections.MicrobiologyOpen · 2026Review
- Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections:Antibiotics (Basel, Switzerland) · 2025Article
- Staphylococcus aureus: Antimicrobial resistance, quorum sensing, and antibiofilm approaches.European journal of microbiology & immunology · 2025Review
- Synthetic High-Throughput Microarrays of Peptidoglycan Fragments as a Novel Sero-Diagnostic Tool for Patient Antibody Profiling.Angewandte Chemie (International ed. in English) · 2025Article
- Peptide-modified mesoporous silica nanoparticles for the coordinated regulation of macrophage polarization and pyroptosis in the treatment of implant-related infections.Materials today. Bio · 2025Article
- Staphylococcal Drug Resistance: Mechanisms, Therapies, and Nanoparticle Interventions.Infection and drug resistance · 2025Review
- Identification of metabolic pathways modulated by GAM and NGAM in the inhibition ofFrontiers in microbiology · 2025Article
- Single-cell Sequencing of Circulating Human Plasmablasts during Staphylococcus aureus Bacteremia.Journal of immunology (Baltimore, Md. : 1950) · 2024Article
- Advances in antibacterial activity of zinc oxide nanoparticles againstBiomedical reports · 2024Review
- Next-generation IgA-SEQ allows for high-throughput, anaerobic, and metagenomic assessment of IgA-coated bacteria.Microbiome · 2024Article
- Monoclonal antibodies: From magic bullet to precision weapon.Molecular biomedicine · 2024Review
- Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to Therapeutics.Pharmaceutics · 2024Review
- Targeting host deoxycytidine kinase mitigateseLife · 2024Article
- Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based onInternational journal of molecular sciences · 2024Review
- In Vivo Detection ofInternational journal of biomedical imaging · 2024Article
- Radioimmunotherapy combating biofilm-associated infectionFrontiers in medicine · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 5 institutions in 3 countries.
Lisanne de Vor *Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0002-2289-3378
Bruce van Dijk *Department of Orthopedics, University Medical Centre Utrecht, Utrecht, Netherlands.
Kok van KesselDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.
Jeffrey S KavanaughDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, United States.
Carla de HaasDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.
Piet C AertsDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.
Marco C ViveenDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.
Edwin C BoelDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0002-8506-0357
Ad C FluitDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.
Jakub M KwiecinskiDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, United States.ORCID 0000-0001-9472-2896
Gerard C KrijgerDepartment of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, Netherlands.
Ruud M RamakersMILabs B.V, Utrecht, Netherlands.
Freek J BeekmanMILabs B.V, Utrecht, Netherlands.
Ekaterina DadachovaCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.ORCID 0000-0001-7300-6479
Marnix Geh LamDepartment of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, Netherlands.
H Charles VogelyDepartment of Orthopedics, University Medical Centre Utrecht, Utrecht, Netherlands.
Bart Ch van der WalDepartment of Orthopedics, University Medical Centre Utrecht, Utrecht, Netherlands.
Jos Ag van StrijpDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.
Alexander R HorswillDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, United States.
Harrie WeinansDepartment of Orthopedics, University Medical Centre Utrecht, Utrecht, Netherlands.
Suzan Hm RooijakkersDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0003-4102-0377
University Medical Center Utrecht · NLUniversity Medical Center · USUniversity of Colorado Denver · USUniversity of Saskatchewan · CAVA Eastern Colorado Health Care System · US
Funding
The S. aureus biofilm lifecycleP01AI083211 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KIELIAN, TAMMY L · 2009 to 2023
$32.1MQuorum Sensing Dependent Interactions with Biofilms and Innate Immunity DefensesI01BX002711 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI ALEXANDER R HORSWILL · 2015 to 2026
–BLRD VA I01 BX002711NIAID NIH HHS P01 AI083211
Abstract
Implant-associated
Indexed as
BiofilmsAnimalsAntibodies, MonoclonalCatheter-Related InfectionsHumansMaleMiceMice, Inbred BALB CStaphylococcal InfectionsStaphylococcus aureusTeichoic AcidsAntibodies, MonoclonalTeichoic Acidsbiofilminfectious diseasemicrobiologymonoclonal antibodiesStaphylococcus aureus
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.